FIAT is co-expressed with its dimerization target ATF4 in early osteoblasts, but not in osteocytes

Vionnie W C Yu1, Omar Akhouayri, René St-Arnaud

  • 1Genetics Unit, Shriners Hospital for Children, 1529 Cedar Avenue, Montreal, Que., Canada H3G 1A6.

Insights

FIAT protein levels decrease during osteoblast differentiation, allowing ATF4 to bind DNA and increase osteocalcin gene transcription. This shift regulates bone formation by controlling osteocalcin expression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Bone Biology

Background:

  • Osteocalcin is a key protein in bone mineralization and remodeling.
  • The transcription factor ATF4 regulates osteocalcin gene expression.
  • FIAT (also known as ZFP36L1) is implicated in regulating gene transcription.

Purpose of the Study:

  • To investigate the expression profiles of FIAT and ATF4 during osteoblastogenesis.
  • To elucidate the regulatory mechanism of osteocalcin gene transcription by FIAT and ATF4.

Main Methods:

  • Quantification of mRNA levels using real-time reverse-transcription PCR (RT-qPCR).
  • Monitoring of protein levels by immunodetection (immunofluorescence and immunoblotting).
  • Immunohistochemistry of mouse long bones at different developmental stages.

Main Results:

  • FIAT and ATF4 mRNA levels remained relatively constant during osteoblast differentiation.
  • FIAT protein levels decreased, while ATF4 protein levels increased over time.
  • Decreased FIAT correlated with increased ATF4 binding to the osteocalcin promoter and elevated osteocalcin expression.

Conclusions:

  • FIAT represses osteocalcin transcription by inhibiting ATF4 DNA binding.
  • A shift in the FIAT/ATF4 protein ratio during osteoblast maturation releases ATF4, promoting osteocalcin gene transactivation.
  • This mechanism highlights the dynamic regulation of osteocalcin during bone formation.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Cells and Tissue01:30

Bone Cells and Tissue

Bones contain a relatively small number of cells entrenched in a matrix of organic and inorganic components. Although bone cells compose only a small amount of the bone volume, they are crucial to its function. Four types of cells are found within the bone tissue— osteoblasts, osteocytes, osteogenic cells, and osteoclasts.
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the periosteum and...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into...
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...